Skip to content
Search

Latest Stories

Ealing shop's license suspended after discovery of 'illicit' drugs

Councillors shocked to find ‘prescription’ drugs at store

An off licence has had its licence suspended after a team from Ealing Council found unmarked illegal items on the premises.


Harcharan Singh claimed he was allowing locals to store their medicines at his shop, King Quality Foods, while they visited the nearby temple.

Singh’s representative, Surendra Panchal, told the panel about the reasons which baffled the chair of the licensing sub-committee, Cllr Anthony Kelly.

Cllr Kelly did not comprehend how a package of drugs would be difficult to fit in someone’s bag, pocket, or car.

The officials found drugs including high blood pressure and diabetes medication at the store.

Moreover, Shane Elliot, Council Officer, discovered a kilo of Indian tobacco as well as 5kg of poppy seeds.

When asked about the confiscation of the poppy seeds, Mr Elliot expressed his belief that, under certain circumstances, they could be categorized as opiates.

However, Mr Panchal pushed back on the assertion, explaining that the poppy seeds could simply be used for a number of "culinary and domestic purposes" and help up a bag of seeds he had bought at a local supermarket.

He did admit that his client had been caught with Indian tobacco and offered an apology on his behalf.

The panel was told that Mr Singh has held his licence since 2019 and has never previously had issues over illicit products.

Although the panel accepted this, one of the sticking points for Cllr Julian Galant was the fact that after the initial discovery of illicit substances being present on the premises, Mr Singh lied about there being more.

However, further items were seized after being found by a police sniffer dog.

The panel displayed clear dissatisfaction with Mr Singh's behaviour and found his explanation regarding the presence of prescription drugs on the premises, including diabetes medication, to be unsatisfactory.

Councillor Brett, the Cabinet member for decent living incomes told Pharmacy Business: “Getting illegal products off the streets of our borough is a key priority for us in keeping our residents safe.

“We will continue to prosecute and crack down on traders who supply any illicit items and counterfeit goods in Ealing. We urge members of the public to be vigilant when purchasing items, especially illegal medicines that can pose a great threat to their health.”

Correction: A previous version of this article included a shopfront image of Quality Foods, 41-67 South Road, Southall. In fact, the illegal items were found at King Quality Food, 72 King Street. We would like to apologise for the use of the incorrect shopfront image and make clear that Quality Foods has no relation to this story.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less